Cytokinetics

ACC 2021: With Amgen out of the picture, Cytokinetics imagines supporting role for omecamtiv in heart failure
Fierce Biotech
Mon, 05/17/21 - 10:48 am
Amgen
Cytokinetics
ACC
Omecamtiv Mecarbil
Astellas quietly cuts Cytokinetics R&D pact as $450M-plus in biobucks goes up in smoke
Fierce Biotech
Mon, 05/3/21 - 10:51 am
Astellas
Cytokinetics
biobucks
Amgen severs 14-year Cytokinetics partnership, bailing on omecamtiv after mixed PhIII results
Endpoints
Mon, 11/23/20 - 10:16 pm
Amgen
Cytokinetics
omecamtiv
clinical trials
AHA 2020 – look out for the omecamtiv fault lines
EP Vantage
Mon, 11/16/20 - 10:13 am
AHA
Omecamtiv Mecarbil
Amgen
Cytokinetics
heart failure
Amgen and Cytokinetics claim heart drug success, but results widely disappoint
BioPharma Dive
Thu, 10/8/20 - 11:19 pm
Amgen
Cytokinetics
Servier
clinical trials
Omecamtiv Mecarbil
cardiovascular disease
Amgen heart drug passes interim check, setting up year-end readout
BioPharma Dive
Wed, 02/26/20 - 11:24 pm
Amgen
Omecamtiv Mecarbil
Cytokinetics
Cytokinetics' comeback attempt with second-gen drug is slammed by a PhII failure in ALS
Endpoints
Sun, 05/5/19 - 06:59 pm
Cytokinetics
clinical trials
reldesemtiv
ALS
Amgen and partners begin second phase 3 trial of omecamtiv mecarbil in patients with heart failure
Pharmaceutical Business Review
Fri, 02/22/19 - 10:04 am
Amgen
heart failure with reduced ejection fraction
Omecamtiv Mecarbil
Cytokinetics
Servier
After a crushing PhIII failure, Cytokinetics says its next-gen muscle drug is lining up well in PhII — but big challenges loom
Endpoints
Mon, 06/18/18 - 10:00 am
Cytokinetics
clinical trials
reldesemtiv
Tirasemtiv
spinal muscular atrophy
Astellas
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
biotech
Axovant Sciences
intepirdine
SAGE Therapeutics
brexanolone
AbbVie
risankizumab
Global Blood Therapeutics
GBT-440
DBV Technologies
Viaskin Peanut
Cytokinetics
Amicus Therapeutics
ATB200
Spark Therapeutics
Bluebird Bio
Revance Therapeutics
RT002
Cytokinetics inches forward with heart failure program
BioPharma Dive
Thu, 08/3/17 - 10:57 am
Cytokinetics
Omecamtiv Mecarbil
Amgen
heart failure
Japan
Cytokinetics reports 4Q loss
Yahoo/AP
Tue, 02/16/16 - 07:45 pm
Cytokinetics
earnings
Cytokinetics, Amgen drug shows promise in heart failure study
Yahoo/Reuters
Mon, 11/9/15 - 10:28 am
Amgen
Cytokinetics
omecamtiv
chronic heart failure
Amgen, Cytokinetics heart failure drug succeeds in mid-stage study
Yahoo/Reuters
Tue, 10/27/15 - 09:56 am
Amgen
Cytokinetics
Omecamtiv Mecarbil
chronic heart failure
How a drug shift set the stage for a potential winner for ALS patients
Bizjournals.com
Thu, 07/16/15 - 09:20 am
ALS
Lou Gehrig's disease
Tirasemtiv
Cytokinetics
5 Bay Area life sciences companies looking to win big in 2015
Bizjournals.com
Mon, 01/5/15 - 10:08 am
Calico Life Sciences
OncoMed
HealthTell
Cytokinetics
Sunesis
Biotech Stocks Make Big Moves In Final Days Of 2014
Yahoo/Benzinga
Wed, 12/31/14 - 11:49 am
NeuroDerm
Arrowhead Research
Rockwell Medical
Redhill Biopharma
Cytokinetics
NephroGenex
Astellas adds to deal spree with expanded $675M-plus Cytokinetics pact
Fierce Biotech
Tue, 12/23/14 - 10:01 am
Astellas
Cytokinetics
CK-2127107
spinal muscular atrophy
Cytokinetics announces additional results relating to Tirasemtiv
The Fly on the Wall
Thu, 07/10/14 - 08:55 am
Cytokinetics
Tirasemtiv
Lou Gehrig's disease
amyotrophic lateral sclerosis
Cytokinetics Still Has Value, Despite Setbacks
Seeking Alpha
Thu, 05/8/14 - 08:28 am
Cytokinetics
Omecamtiv Mecarbil
Tirasemtiv

Pages